These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6896786)
1. In vitro lymphocyte proliferation in response to polyclonal activators and microbial antigens, and production of immunoglobulins stimulating thyroid adenylate cyclase in Graves' disease. Bech K; Andersen V; Madsen SN Acta Endocrinol (Copenh); 1982 Jun; 100(2):252-5. PubMed ID: 6896786 [TBL] [Abstract][Full Text] [Related]
2. Evidence of a correlation between thyrotrophin receptor binding inhibition and thyroid adenylate cyclase activation by immunoglobulins in Graves' disease before and during long-term antithyroid treatment. Bliddal H; Bech K; Hyltoft Petersen P; Siersbaek-Nielsen K; Friis T Acta Endocrinol (Copenh); 1982 Sep; 101(1):35-40. PubMed ID: 6181640 [TBL] [Abstract][Full Text] [Related]
3. Thyroid antigen stimulates lymphocytes from patients with Graves' disease to produce thyroid-stimulating immunoglobulin (TSI). Knox AJ; von Westarp C; Row VV; Volpé R J Clin Endocrinol Metab; 1976 Aug; 43(2):330-7. PubMed ID: 181397 [TBL] [Abstract][Full Text] [Related]
5. The production of thyroid-stimulating immunoglobulin (TSI) by lymphocytes from patients with Graves' disease cultured with human thyroid subcellular fractions. Sugenoya A; Trokoudes K; Row VV; Volpé R J Endocrinol Invest; 1978 Jul; 1(3):245-51. PubMed ID: 583156 [No Abstract] [Full Text] [Related]
6. A sensitive method for assaying thyroid stimulating immunoglobulins of Graves' disease: use of the guanyl nucleotide-amplified thyroid adenylate cyclase assay. Macchia E; Carayon P; Fenzi GF; Lissitzky S; Pinchera A Acta Endocrinol (Copenh); 1983 Jul; 103(3):345-51. PubMed ID: 6688318 [TBL] [Abstract][Full Text] [Related]
8. Adenylate cyclase stimulation and [3H]thymidine incorporation in human thyroid tissues and thyrocyte cultures: the effect of IgG preparation from patients with different thyroid disorders. Goretzki PE; West M; Koob R; Koller C; Joseph K; Röher HD Acta Endocrinol Suppl (Copenh); 1987; 281():281-7. PubMed ID: 3475910 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment. Bliddal H; Bech K; Siersbaek-Nielsen K; Friis T J Endocrinol Invest; 1983 Aug; 6(4):259-62. PubMed ID: 6139399 [TBL] [Abstract][Full Text] [Related]
10. Immunoglobulins of patients recovering from Yersinia enterocolitica infections exhibit Graves' disease-like activity in human thyroid membranes. Wolf MW; Misaki T; Bech K; Tvede M; Silva JE; Ingbar SH Thyroid; 1991; 1(4):315-20. PubMed ID: 1688156 [TBL] [Abstract][Full Text] [Related]
11. In vitro production of thyroid-binding antibodies by peripheral blood lymphocytes from patients with Graves' disease: nonspecific responses associated with culture supernatant proteins. Wall JR; Strakosch CR; Trewin A; Joyner DM J Endocrinol Invest; 1979; 2(3):261-6. PubMed ID: 583343 [TBL] [Abstract][Full Text] [Related]
12. Use of FRTL-5 for the study of thyroid antibodies involved in goitrogenesis. Vitti P; Chiovato L; Tonacchera M; Bendinelli G; Mammoli C; Capaccioli A; Giachetti M; Pinchera A Thyroidology; 1992 Apr; 4(1):49-51. PubMed ID: 1284334 [TBL] [Abstract][Full Text] [Related]
13. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition. Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093 [TBL] [Abstract][Full Text] [Related]
14. Graves' IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: a clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease. Marcocci C; Valente WA; Pinchera A; Aloj SM; Kohn LD; Grollman EF J Endocrinol Invest; 1983 Dec; 6(6):463-71. PubMed ID: 6689493 [TBL] [Abstract][Full Text] [Related]
16. Detection of tsh binding inhibiting antibodies (TBI-ab) and thyroid adenylate cyclase stimulating antibodies (TS-ab) in sera of patients with Graves' disease. Lattanzi V; Scardapane R; Ciampolillo A; Vincenti C; Giorgino R Boll Soc Ital Biol Sper; 1985 Jan; 61(1):55-60. PubMed ID: 3838478 [TBL] [Abstract][Full Text] [Related]
17. Abnormal B lymphocyte function in thyroid glands from patients with Graves' disease. Ueki Y; Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Tezuka H; Nakao H; Kawakami A; Migita K; Ishikawa J Clin Endocrinol Metab; 1989 Nov; 69(5):939-45. PubMed ID: 2793996 [TBL] [Abstract][Full Text] [Related]
18. Regulation of intercellular adhesion molecule-1 expression in human thyroid cells in vitro and human thyroid tissue transplanted to the nude mouse in vivo: role of Graves' immunoglobulins and human thyrotropin receptor. Hoermann R; Spitzweg C; Poertl S; Mann K; Heufelder AE; Schumm-Draeger PM J Clin Endocrinol Metab; 1997 Jul; 82(7):2048-55. PubMed ID: 9215271 [TBL] [Abstract][Full Text] [Related]
19. Can the inhibition of prostaglandin synthesis affect the adenylate cyclase response to thyroid stimulating antibodies? Macchia E; Fenzi GF; Concetti R; Borgoni F; Pinchera A J Endocrinol Invest; 1985 Dec; 8(6):567-70. PubMed ID: 2871066 [TBL] [Abstract][Full Text] [Related]
20. Thyroid autoantibody synthesis by cultures of thyroid and peripheral blood lymphocytes. I. Lymphocyte markers and response to pokeweed mitogen. McLachlan SM; Dickinson AM; Malcolm A; Farndon JR; Young E; Proctor SJ; Smith BR Clin Exp Immunol; 1983 Apr; 52(1):45-53. PubMed ID: 6602673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]